Data as of Jul 25
| -4.56 / -7.26%|
The 6 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 64.00, with a high estimate of 71.00 and a low estimate of 52.00. The median estimate represents a +9.85% increase from the last price of 58.26.
The current consensus among 7 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.